Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q2 2025 Earnings Call Transcript

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Q2 2025 Earnings Call Transcript August 11, 2025

Karyopharm Therapeutics Inc. misses on earnings expectations. Reported EPS is $-4.32 EPS, expectations were $-3.8.

Operator: Good morning. My name is Ludy, and I will be your conference operator today. At this time, I would like to welcome everyone to the Karyopharm Therapeutics Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please be advised that this call is being...